A detailed history of Cito Capital Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cito Capital Group, LLC holds 16,200 shares of GILD stock, worth $1.43 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
16,200
Previous 16,200 -0.0%
Holding current value
$1.43 Million
Previous $1.19 Million 6.4%
% of portfolio
0.43%
Previous 0.49%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$71.58 - $87.29 $35,790 - $43,645
500 Added 3.18%
16,200 $1.19 Million
Q2 2022

Aug 15, 2022

SELL
$57.72 - $65.01 $115,440 - $130,020
-2,000 Reduced 11.3%
15,700 $970,000
Q2 2021

Aug 16, 2021

BUY
$63.47 - $69.35 $63,470 - $69,350
1,000 Added 5.99%
17,700 $1.22 Million
Q4 2020

Feb 16, 2021

BUY
$56.65 - $64.55 $67,980 - $77,460
1,200 Added 7.74%
16,700 $973,000
Q4 2019

Feb 13, 2020

SELL
$61.62 - $67.78 $24,648 - $27,112
-400 Reduced 2.52%
15,500 $1.01 Million
Q2 2019

Aug 14, 2019

BUY
$61.87 - $69.38 $6,187 - $6,938
100 Added 0.63%
15,900 $1.07 Million
Q3 2018

Nov 13, 2018

BUY
$71.28 - $78.92 $28,512 - $31,568
400 Added 2.6%
15,800 $1.22 Million
Q2 2018

Jul 03, 2018

BUY
$64.88 - $75.68 $25,952 - $30,272
400 Added 2.67%
15,400 $1.09 Million
Q3 2017

Nov 13, 2017

BUY
$72.11 - $85.47 $1.08 Million - $1.28 Million
15,000
15,000 $0

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Cito Capital Group, LLC Portfolio

Follow Cito Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cito Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cito Capital Group, LLC with notifications on news.